Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.085 USD | -0.12% | +5.56% | +9.22% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.22% | 466M | |
-1.56% | 104B | |
+6.57% | 97.47B | |
+5.71% | 22.25B | |
-12.95% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.82% | 16.36B | |
+8.28% | 14.39B | |
+37.06% | 12.37B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- GT Biopharma, Fate Therapeutics Say Preclinical Data Shows Potential of New Approach to Treat Leukemia